These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1940467)

  • 1. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Pestel M; Kitzis MD; Lemeland JF; Humbert G; Gutmann L
    J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Lemeland JF; Humbert G; Klare I; Gutmann L
    J Infect Dis; 1993 Sep; 168(3):681-6. PubMed ID: 8354909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B; Leclercq R; Arthur M; Duval J; Carbon C
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Kitzis MD; Gutmann L; Cremieux AC; Maziere B; Vallois JM; Saleh-Mghir A; Lemeland JF; Carbon C
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2611-6. PubMed ID: 1336339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium.
    Torres C; Tenorio C; Lantero M; Gastañares MJ; Baquero F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2427-31. PubMed ID: 8285628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
    Zaman MM; Landman D; Burney S; Quale JM
    J Antimicrob Chemother; 1996 Jan; 37(1):127-32. PubMed ID: 8647753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
    Landman D; Quale JM; Mobarakai N; Zaman MM
    J Antimicrob Chemother; 1995 Jul; 36(1):253-8. PubMed ID: 8537276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
    Whitman MS; Pitsakis PG; Zausner A; Livornese LL; Osborne AJ; Johnson CC; Levison ME
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2069-73. PubMed ID: 8257125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocarditis due to high level gentamicin resistant Enterococcus faecium.
    Das SS; Anderson JR; Macdonald AA; Somerville KW
    J Infect; 1994 Mar; 28(2):185-91. PubMed ID: 8034999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis.
    Marangos MN; Nicolau DP; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1997 Apr; 39(4):519-22. PubMed ID: 9145826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
    Matsumura S; Simor AE
    Clin Infect Dis; 1998 Dec; 27(6):1554-6. PubMed ID: 9868693
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
    Antony SJ; Matherin P; Stratton C
    Scand J Infect Dis; 1995; 27(4):401-3. PubMed ID: 8658079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model.
    Zelenitsky SA; Booker B; Laing N; Karlowsky JA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 1999 Mar; 43(3):592-7. PubMed ID: 10049272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.